NYSE:MCK
NYSE:MCKHealthcare

Should You Reassess McKesson After Its Double Digit Gains and CVS Collaboration in 2025?

If you are keeping an eye on McKesson stock these days, you are hardly alone. Whether you are a current shareholder, thinking about jumping in, or just watching for cues from one of healthcare’s giants, recent movements in MCK have definitely stirred up conversation. In the past year alone, the stock has gained nearly 24%, a run that easily outpaces the broader market and hints at serious momentum. For those with a longer view, the total return over five years has soared to more than 360%,...
NYSE:FUN
NYSE:FUNHospitality

How Investors Are Reacting To Six Flags (FUN) Expanding Premium Halloween Experiences and Announcing Leadership Changes

Six Flags Entertainment recently unveiled expanded Halloween events with new premium interactive horror experiences across 25 parks, alongside second quarter earnings and leadership transition announcements. The rollout of The Conjuring: Beyond Fear and exclusive season pass offerings signals an emphasis on immersive attractions to boost guest engagement and potential revenue streams. We’ll examine how the launch of new premium Halloween experiences influences Six Flags’ future growth and...
NYSE:LEN
NYSE:LENConsumer Durables

How High Can Lennar Go After 22% Rally and Strong Earnings Report?

Thinking about what to do with Lennar stock right now? You are not alone. After all, Lennar’s share price has taken investors on a surprisingly lively ride lately. Over the last 30 days, the stock jumped an impressive 22.5%, while the 90-day picture looks even rosier with a surge of nearly 27%. Results like these can make anyone wonder if there is still room to run or if all the growth has been priced in. Of course, there was a rough patch earlier this year, and the one-year return is still...
NasdaqGS:TER
NasdaqGS:TERSemiconductor

Is Teradyne’s Recent 40% Rally Justified After May’s Strong Earnings Beat?

If you have Teradyne on your watchlist or already own shares, you have probably noticed some pretty dramatic moves lately. In the past three months, TER’s stock price is up over 40%, a remarkable surge driven by optimism around the semiconductor sector and renewed confidence in the company’s growth story. Yet, year to date, the stock is still down nearly 13%, and the total return over the past year sits at around -15%. That kind of bounce and pullback can make any investor wonder whether now...
NasdaqCM:MVST
NasdaqCM:MVSTMachinery

Microvast Holdings (MVST) Reports Q2 2025 Sales Growth Despite Continued Net Loss

Microvast Holdings (MVST) recently announced its Q2 2025 earnings report, showing a growth in sales but a continued net loss. Despite a positive revenue outlook for the year, the company's share price fell 13% over the past week. This decline may be influenced by the broader market trend, where major indices like the Nasdaq slid due to a slump in tech stocks. Additionally, the appointment of an interim CFO amidst leadership transitions could have added uncertainty. The company's performance...
NasdaqGS:BNTX
NasdaqGS:BNTXBiotechs

Health Canada Approves Variant-Adapted Vaccine By BioNTech (BNTX)

BioNTech (BNTX) recently experienced a 10% price increase in the last quarter, coinciding with the Health Canada's authorization of its variant-adapted COMIRNATY COVID-19 vaccine, a potential positive catalyst. During this period, BioNTech also benefited from positive updates such as the European Medicines Agency's recommendation for its COVID-19 vaccine and the narrowing of net losses reported in Q2, reinforcing investor confidence. Meanwhile, broader market trends showed a general rise,...